找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Oxidative Stress and Neuroprotection; H. Parvez,P. Riederer Book 2006 Springer-Verlag Vienna 2006 Alzheimer.Morbus Parkinson.Parkinson.alz

[復制鏈接]
樓主: Buchanan
11#
發(fā)表于 2025-3-23 12:28:55 | 只看該作者
PD-related psychosis: pathophysiology with therapeutical strategies, considered to represent major contributors to patient and caregiver distress and nursing home placement..Endogenous (related to the disease process itself) as well as exogenous (related to therapeutical interventions) psychotogenic factors may contribute to the development of psychotic symptoms in
12#
發(fā)表于 2025-3-23 14:01:28 | 只看該作者
13#
發(fā)表于 2025-3-23 18:52:28 | 只看該作者
14#
發(fā)表于 2025-3-23 22:21:55 | 只看該作者
,Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson’s diseasn and neuromelanin. MAO B inhibitors such as L-(?)-deprenyl (selegiline) and rasagiline are effective for the treatment of PD. Concerning the mechanism of the clinical efficacy of MAO B inhibitors in PD, the inhibition of DA degradation (a symptomatic effect) and also the prevention of the formation
15#
發(fā)表于 2025-3-24 02:52:23 | 只看該作者
16#
發(fā)表于 2025-3-24 08:02:37 | 只看該作者
17#
發(fā)表于 2025-3-24 13:58:25 | 只看該作者
,Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson’s disease induced by the Japanesen, but not selegiline. These findings suggest that JEV-infected rats may serve as a model of Parkinson’s disease and that exogenously administered isatin and selegiline can improve JEV-induced parkinsonism by increasing DA concentrations in the striatum.
18#
發(fā)表于 2025-3-24 18:39:50 | 只看該作者
,Neuroprotection for Parkinson’s disease, clinical investigation can be increased. Recent years have seen the utilization of more sensitive study methods in PD neuroprotection research, such as staggered wash-in, 2 × 2 factorial, and “futility” trial designs. The results of several ongoing PD neuroprotection trials are planned for release
19#
發(fā)表于 2025-3-24 21:21:17 | 只看該作者
20#
發(fā)表于 2025-3-25 01:42:58 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 17:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
龙江县| 延川县| 台南市| 大方县| 阳春市| 濮阳市| 隆化县| 灵川县| 蒙阴县| 新和县| 德州市| 天等县| 英吉沙县| 三穗县| 公主岭市| 惠安县| 贵定县| 神池县| 南昌市| 云南省| 额敏县| 昌乐县| 礼泉县| 高陵县| 昭苏县| 合江县| 盐源县| 涿鹿县| 商洛市| 改则县| 横山县| 石渠县| 天峨县| 香格里拉县| 钟祥市| 东方市| 南昌市| 阿图什市| 滦南县| 博爱县| 莱州市|